GAM
CDMO

Gotham Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Gotham Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,494
Closed -$315K – 1332
2022
Q3 		$315K Buy
16,494
+2,985
+22% +$54.4K 0.01% 968
2022
Q2 		$206K Buy
+13,509
New +$200K 0.01% 1038

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Gotham Asset Management's CDMO Position: Q4 2022 in Review

Gotham Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2022, closing a stake of 16,494 shares — an estimated $315K sold.

Gotham Asset Management first reported a position in CDMO in Q2 2022 and held it in 2 quarters. The position peaked at $315K in Q3 2022. 168 funds tracked by Wall St. Rank hold CDMO as of Q4 2022.

  • Gotham Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Gotham Asset Management sold 16,494 Avid Bioservices, Inc. Common Stock shares in Q4 2022, an estimated $315K.
  • Gotham Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Gotham Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $315K in Q3 2022.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2022.

Based on Gotham Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.